Senior Clinical Investigator Of The Research Foundation - Flanders
CurrentWith my personal funding secured until 2020 my primary goal is to bring the new therapeutic modalities we have been working on in the Speleman and Vandesompele labs to the clinic. Detailed genomic profiling of primary and relapse paediatric tumors should enable us to direct patients towards their optimal phase I or II clinical trials over the following years. In close collaboration with the Innovative therapies for children with cancer consortium (ITCC) our aim is to start early phase clinical trials targeting the oncogenic pathways we have helped unravel over the past decade.